Effects of Postbiotics Derived from Guava (Psidium guajava L.) Leaf Extract Bioconverted by Limosilactobacillus fermentum on Renal Inflammation in Type 2 Diabetic Mice
Nutrients · 2025
DOI: 10.3390/nu17193084 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Nayoung Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food and Nutrition, Kyung Hee University, 26 Kyunghee-Daero, Dongdaemun-Gu, Seoul 02447, Republic of Korea. Hauptthemen laut MEDLINE: Plant Extracts, Psidium, Diabetes Mellitus, Type 2, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Science and Technology.
Abstract (Originalsprache)
Background/Objectives: Diabetic nephropathy (DN) is a major complication of diabetes and a leading cause of end-stage renal disease, a condition associated with high mortality risks. Recently, supplementation with probiotics and postbiotics has been attracting attention. Especially, metabolites of natural products bioconverted by beneficial bacteria have emerged as a novel therapeutic intervention for metabolic diseases, including diabetes, due to the enhanced bioavailability of their metabolites. This study investigated the alleviating effects of metabolites derived from guava leaf extract bioconverted by Limosilactobacillus fermentum (GBL) on renal inflammation in type 2 diabetic mice.
Methods
For this purpose, diabetes was induced in male C57BL/6J mice by a high-fat diet and streptozotocin injection (80 mg/kg BW) twice. Subsequently, mice with fasting blood glucose levels higher than 300 mg/dL were administered metabolites of L. fermentum (LF) (50 mg/kg BW/day) or guava leaf extract bioconverted by L. fermentum (GBL) (50 mg/kg BW/day) by oral gavage for 15 weeks.
Results
GBL demonstrated potential in alleviating hyperglycemia-induced DN in diabetic mice. It markedly improved hyperglycemia, glucose tolerance, and morphological alterations, which might stem from activation of key regulators of energy metabolism. GBL uniquely reduced advanced glycation end products (AGEs) and suppressed nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)-driven inflammatory pathways, which significantly alleviated oxidative stress and apoptosis.
Conclusions
This highlights the distinct therapeutic efficacy of GBL in addressing DN, primarily through its effects on renal inflammation. Taken together, GBL can be used as a promising nutraceutical to mitigate hyperglycemia and its associated renal inflammation, thereby alleviating the progression of DN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food and Nutrition, Kyung Hee University, 26 Kyunghee-Daero, Dongdaemun-Gu, Seoul 02447, Republic of Korea.
- Department of Food Science and Nutrition, Hallym University, Chuncheon 24252, Republic of Korea.
- Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea.
ORCID-Profile: Yunsook Lim
Förderung
- Ministry of Education, Science and Technology
Zitieren
APA
Park, N., Lee, H., Lee, C. H., & Lim, Y. (2025). Effects of Postbiotics Derived from Guava (Psidium guajava L.) Leaf Extract Bioconverted by Limosilactobacillus fermentum on Renal Inflammation in Type 2 Diabetic Mice. Nutrients. https://doi.org/10.3390/nu17193084
Vancouver
Park N, Lee H, Lee CH, Lim Y. Effects of Postbiotics Derived from Guava (Psidium guajava L.) Leaf Extract Bioconverted by Limosilactobacillus fermentum on Renal Inflammation in Type 2 Diabetic Mice. Nutrients. 2025. doi:10.3390/nu17193084
BibTeX
@article{Park2025,
author = {Park, Nayoung and Lee, Heaji and Lee, Choong-Hwan and Lim, Yunsook},
title = {Effects of Postbiotics Derived from Guava (Psidium guajava L.) Leaf Extract Bioconverted by Limosilactobacillus fermentum on Renal Inflammation in Type 2 Diabetic Mice},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17193084}
}
EUVIMED